RenovoRx
RNXT
13 hedge funds and large institutions have $2M invested in RenovoRx in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
98% more capital invested
Capital invested by funds: $1.01M → $2M (+$992K)
4.14% more ownership
Funds ownership: 3.74% → 7.88% (+4.1%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
24% less funds holding
Funds holding: 17 → 13 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.09M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$99.7K |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$39.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.04K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$44.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$29.6K |
| 3 |
HF
HRT Financial
New York
|
-$13K |
| 4 |
Renaissance Technologies
New York
|
-$11.3K |
| 5 |
BlackRock
New York
|
-$10.4K |
RNXT Hedge Fund Activity: Q3 2024 in Review
13 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q3 2024, worth a combined $2M — up 98% from $1.01M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RNXT and 2 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $1.09M. The largest seller was ADAR1 Capital Management, cutting an estimated $44.9K.
- 13 institutional investors held RenovoRx (RNXT) as of Q3 2024, down from 17 in Q2 2024.
- Funds reported $2M of RenovoRx stock for Q3 2024, up 98% quarter-over-quarter.
- 2 funds opened new RenovoRx positions in Q3 2024 and 6 closed out, a net change of -4 holders.
- The largest RenovoRx buyer in Q3 2024 was Bank of Montreal, an estimated $1.09M added.
- The largest RenovoRx seller in Q3 2024 was ADAR1 Capital Management, an estimated $44.9K sold.
Based on aggregated 13F filings for Q3 2024.